Skip to main content
Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
3.990
-0.020 (-0.50%)
Dec 20, 2024, 4:00 PM EST - Market closed

Biodexa Pharmaceuticals Stock Forecast

BDRX's stock price has decreased by -93.98% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 1 analyst with a 12-month price forecast for BDRX stock has a target of 200, which predicts an increase of 4,912.53% from the current stock price of 3.99.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $200 $200 $200 $200
Change +4912.5% +4912.5% +4912.5% +4912.5%
* Price targets were last updated on Feb 8, 2024.

Analyst Ratings

According to 1 stock analyst, the rating for BDRX is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Feb '24
Strong Buy 1
Buy 0
Hold 0
Sell 0
Strong Sell 0
Total 1

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Aydin Huseynov
Ladenburg Thalmann
 Ladenburg Thalmann
Strong Buy
Initiates
$200
 Strong Buy Initiates $200 +4,912.53% Feb 8, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
33.96K
from 381.00K
Decreased by -91.09%
Revenue Next Year
16.98K
from 33.96K
Decreased by -49.98%
EPS This Year
-3.92
from -224.13
EPS Next Year
-2.61
from -3.92
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
674.00K343.00K578.00K699.00K381.00K33.96K16.98K7.83K
Revenue Growth
-65.22%-49.11%68.51%20.93%-45.49%-91.09%-49.98%-53.87%
EPS
-----224.13-3.92-2.61-2.94
EPS Growth
--------
Forward PE
--------
No. Analysts -----333
Financial currency is GBP. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 2024202520262027
High 34,955 17,483 8,064
Avg 33,956 16,983 7,834
Low 32,624 16,317 7,526

Revenue Growth

Revenue Growth 2024202520262027
High
-90.8%
-48.5%
-52.5%
Avg
-91.1%
-50.0%
-53.9%
Low
-91.4%
-51.9%
-55.7%

EPS Forecast

EPS 2024202520262027
High -4.03 -2.69 -3.03
Avg -3.92 -2.61 -2.94
Low -3.76 -2.51 -2.82

EPS Growth

EPS Growth 2024202520262027
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.